In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

President Donald Trump’s pick to lead the U.S. Department of Agriculture said during her confirmation hearing Thursday that ...

We recently compiled a list of the 8 Best Humane Stocks to Invest in Now. In this article, we are going to take a look at ...

Mr. John DeLucia, as a well-respected Regulatory Consultant, is representing Izotropic in its pre-submission interactions with FDA while ensuring the Company's proposals, documentation, filings, and ...

With little competition on the market for Casgevy, a price of $2.2 million in the U.S., increased third-party coverage, and a total target ... the U.S. Food and Drug Administration (FDA) granted ...

European markets closed higher on Friday, buoyed by robust Chinese growth data and merger talks in the mining sector.

The Trump administration’s budget freeze on federal grants and loans will affect more than 2,600 accounts across the ...